
MUMBAI, India, and NAPLES, Fla., July 28, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval under the Federal Food, Drug, and…

Driven by Strict EU MDR Mandates and a 30% Decrease in Medication Errors via Ready-to-Administer Formats, the Global Industry is Poised to Scale Beyond USD 3.8 Billion by 2036, Reports Future Market Insights NEWARK, Del., June 18, 2026 /PRNewswire/ -- Accordi…

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Deepa Jewellers, a B2B hallmarked gold jewellery processor based in Hyderabad, and Cotec Healthcare, a pharmaceutical CDMO, both received SEBI approval for their IPOs. Deepa's IPO includes a Rs 250 crore fresh issue and an offer for sale by promoters.
The menopause care market is expanding due to growing awareness of women's health, innovative hormone therapies, and digital health solutions. Key opportunities lie in hormone therapy, plant-based supplements, AI-driven apps, and telehealth, addressing divers…
The AI in life sciences market is experiencing robust expansion due to several important factors. Rising demand for accelerated drug discovery and development is prompting pharmaceutical and biotechnology companies to implement AI technologies that can shorte…
By Rishika Sadam HYDERABAD, May 12 (Reuters) - Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules against advertising prescription medicines to consumers even indirectly...

The DNA synthesis market is witnessing strong adoption across pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and synthetic biology firms due to its critical role in enabling advanced genet…
The course presents market opportunities in enhancing technology transfer processes for solid dosage forms, focusing on scale-up, strategy, and practical solutions in the pharmaceutical industry. Participants gain tools for effective implementation, addressin…
The clinical trials market is forecasted to experience strong growth, expanding from $92.63 billion to $158.1 billion between 2025 and 2034, driven by rising pharmaceutical and biotechnology R&D, chronic disease prevalence, and demand for innovative treatment…